Results 21 to 30 of about 35,850 (218)
Diagnostics, 2023 Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades.
Ojone Illah, Adeola Olaitan
openaire +3 more sources
SAGE Open, 2023 Despite strenuous efforts to increase vaccination rates against human papillomavirus (HPV), the rate of vaccination remains low in the U.S. The COVID-19 pandemic poses an additional challenge to HPV vaccination.
ShinHi Han +4 more
doaj +1 more source
JMIR Public Health and Surveillance, 2022 BackgroundThe human papillomavirus (HPV) vaccine is recommended for adolescents and young adults to prevent HPV-related cancers and genital warts.
Akshaya Srikanth Bhagavathula +1 more
doaj +1 more source
Vaccine: X, 2023 Objective: To examine the knowledge of cervical cancer risk factors and human papilloma virus (HPV) vaccine among Saudi women of childbearing age. Methods: An anonymous, survey-based, cross-sectional study was conducted from November 2022 to March 2023 ...
Abdulrahim Gari +8 more
doaj +1 more source
Prophylactic HPV vaccines [PDF]
Journal of Clinical Pathology, 2007 The HPV L1 VLP vaccines are immensely important developments in public health and the benefits that they promise are immense, offering the opportunity to prevent, in the long term, 80% of cervical cancers, 60% of vulval cancers and 80% of anal cancers in women. In the short to medium term they will prevent at least 90% of genital warts and have a major
openaire +3 more sources
VaccinesBackground: West Virginia is of particular concern regarding HPV vaccine hesitancy, currently ranking 45th among U.S. states in HPV vaccine uptake. General vaccine hesitancy and HPV- and HPV vaccine-specific misinformation, both associated with lower ...
Jeanine P. D. Guidry +9 more
doaj +1 more source
HPV Vaccine Hesitancy Among Medical Students in China: A Multicenter Survey
Frontiers in Public Health, 2022 Human papillomavirus (HPV) is the most common genital tract virus infection and can cause genital warts and cervical cancer. This multicenter study examined HPV information sources, vaccine hesitancy, and the association between the two variables.
Liangru Zhou +5 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Vaccine confidence reflects social, individual, and political factors indicating confidence in vaccines and associated health systems. In Japan, the government ceased proactive recommendation of the human papillomavirus (HPV) vaccine in June 2013, only ...
Michiko Shuto +8 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 The delivery of strong HPV vaccine recommendations hinges on the expertise of healthcare providers (HCPs) in assessing patients' status and recommending HPV vaccination. We conducted a population-based cross-sectional study of HCPs practicing in Texas to examine the relationship between HPV vaccination training of HCPs and HPV vaccination status ...
Ikponmwosa Osaghae +7 more
openaire +4 more sources
Engineering Microbial Particles for Next‐Generation Biomedical Platforms
Advanced Science, EarlyView.Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li +7 more
wiley +1 more source